Beruflich Dokumente
Kultur Dokumente
65 to 85 Years of Age
Francisco Garcia-Rio1, Ali Dorgham1, Jose M. Pino1, Carlos Villasante1, Cristina Garcia-Quero1,
and Rodolfo Alvarez-Sala1
1
(Received in original form January 23, 2009; accepted in final form September 3, 2009)
Supported by FIS (99/0218) and NEUMOMADRID grants.
Correspondence and requests for reprints should be addressed to Francisco
Garcia-Rio, Ph.D., Alfredo Marquerie 11, izqda 1A, Madrid, 28034, Spain; E-mail:
fgr01m@gmail.com
This article has an online supplement, which is accessible from this issues table of
contents at www.atsjournals.org
Am J Respir Crit Care Med Vol 180. pp 10831091, 2009
Originally Published in Press as DOI: 10.1164/rccm.200901-0127OC on September 10, 2009
Internet address: www.atsjournals.org
AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
data acquired in studies of younger adults. Remarkable differences in these predicted values may be ascribed to the selection
of subjects and to methodologic or technical differences in the
assessment. Moreover, because most of the studies were performed at least two decades ago, they may not fit present-day
populations due to cohort effects.
The main limitation of applying prediction equations derived
from primarily younger adult populations to older adults might
come from the morphologic and functional changes in the
respiratory system related to ageing (12, 13). Structural changes
associated with ageing include smaller airway size, an increase
in alveolar duct diameter with a concomitant change in the
morphology of the alveolar sacs (which become larger), a decrease in lung elastic tissue, and an increase in lung collagen
concentrations and in the proportion of type III collagen (12, 14,
15). These morphologic changes, in addition to a decrease in
chest wall compliance and a decrease in respiratory muscle
strength, produce several changes in the pulmonary function of
elderly subjects, such as a decrease in the static elastic recoil of
the lung, an increase in pulmonary compliance, and small airway
closure resulting in air trapping (13, 16).
In addition to the obvious consequences that these alterations might have on static lung volumes, the calculation of
these volumes might be affected by the measurement procedures used. Because the plethysmographic and dilutional
methods give the same results in healthy adults, the reference
values derived from these techniques are used interchangeably
in adults (5, 6). However, the existence of air trapping in elderly
subjects might result in a significant underestimation of true
lung volumes measured by helium dilution as compared with
plethysmography.
The aims of this paper are to provide reference equations for
static lung volumes for a cohort of healthy never-smoking white
European adults between 65 and 85 years of age and to compare
the predicted values of this sample with those from other studies
including middle-aged adults. In addition, we compare the
measurements of lung volumes by plethysmography and helium
dilution in healthy elderly subjects.
1084
METHODS
Subjects
A random sample of never-smoker subjects without respiratory or
cardiovascular disease was recruited from the elderly population of the
Madrid metropolitan area (17).
Screening was based on a combination of questionnaire on respiratory symptoms (18), physical examination, and chest radiograph
and electrocardiography evaluation. A detailed description of the
exclusion criteria and the subject selection procedure is contained in
the online supplement. The study was approved by the local Ethics
Committee, and informed consent was obtained from all subjects.
Methods
Subjects were weighed and measured while wearing indoor clothing
without shoes, and body mass index (BMI) and body surface area
(BSA) were calculated. Age was recorded to the nearest birthday.
Lung function tests were performed with a MasterLab 4.6 system
(Jaeger, Wurtzburg, Germany). After a spirometry following ATS/
ERS recommendations (19), lung volumes were determined using
a variable-pressure plethysmograph, also in accordance with ATS/
ERS recommendations (20). Thoracic gas volume at the level of
functional residual capacity (FRCpleth) was measured while the subjects made gentle breathing movements against the shutter at a rate of
less than 1/s (5). Expiratory reserve volume (ERV) and inspiratory VC
were measured during the same maneuver. FRCpleth was reported as
the mean of three or more measurements that differed by less than 5%.
Residual volume (RVpleth) was calculated as FRCpleth 2 ERV and
TLCpleth as FRCpleth 1 VC. Airway resistance was computed from
pressure and flow measurements breathing warm, moist air fulfilling
BTPS conditions (21).
Thirty minutes afterward, lung volumes were measured using the
multibreath helium equilibration method. The closed circuit was filled
with a mixture of 10% He, 35% O2, and 55% N2. A helium thermal
2009
Analysis
Values are expressed as mean 6 SD. Lung volumes were compared
by paired Students t test, and agreement between pairs was analyzed
(21). Independent variables considered for inclusion in the models
were age, standing height, weight, BMI, BSA, and their exponential,
logarithmic, or square root transformations. In the multiple linear
regression analysis, predictor variables were retained only if their
addition significantly improved the fraction of explained variability
(R2). The assumptions of linearity and distributional normality were
controlled. The lower limit of normal (LLN) range was calculated as
follows: predicted value 1.645 3 RSD (where RSD is the residual
standard deviation).
The selection of prediction equations for comparison was based on
common use (410). Differences between observed and predicted
values are given as mean difference, mean squared difference, and
standardized prediction deviation. For comparisons among authors,
LLN was calculated using the RSD of the corresponding equation. The
differences between predicted values based on the prediction equations
from the present study and others are given as Bland and Altman plots.
Statistical significance was assumed for P , 0.05.
RESULTS
A total of 583 subjects underwent clinical evaluation; 201
subjects were excluded due to dyspnea (n 5 24), cough (n 5
17), wheezing (n 5 13), or for several previously undetected
73
152
61
26.4
1.58
2.29
1.80
78.9
0.83
2.39
0.92
1.57
3.73
2.12
1.40
37.3
57.2
3.91
2.34
1.52
38.7
60.1
39.9
0.49
1.30
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6*
6
7
2.4
0.11
0.47
0.41
5.6
0.40
0.48
0.44
0.47
0.68
0.46
0.40
7.9
8.3
0.69
0.47
0.43
7.7
8.6
8.5
0.29
0.71
Men (n 5 132)
72
166
73
26.6
1.81
3.46
2.65
76.8
1.20
3.65
1.45
2.45
5.41
2.91
1.73
31.7
54.5
5.59
3.14
1.94
34.3
56.8
43.2
0.34
1.21
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
6
8
2.2
0.12
0.64
0.52
5.5
0.46
0.65
0.66
0.73
1.02
0.60
0.58
8.3
9.1
0.99
0.57
0.56
7.0
8.7
8.7
0.17
0.51
Definition of abbreviations: BMI 5 body mass index; BSA 5 body surface area;
ERV 5 expiratory reserve volume; FRCHe 5 functional residual capacity by helium
dilution; FRCpleth 5 functional residual capacity by plethysmography; IC 5
inspiratory capacity; IRV 5 inspiratory reserve volume; Raw 5 airway resistance;
RVHe 5 residual volume by helium dilution; RVpleth 5 residual volume by
plethysmography; sRaw 5 specific airway resistance; TLCHe 5 total lung capacity
by helium dilution; TLCpleth 5 total lung capacity by plethysmography.
* Values are mean 6 SD.
1085
In men and in women, the plethysmographic method provided higher values than the dilutional method for TLC, FRC,
or RV (P , 0.001 in all comparisons) (Table 1). The mean
differences of lung volumes (plethysmographic 2 helium dilution) and their 95% limits of agreement were wide, reflecting
as great a within-subject variability as that from method-related
differences (Figure 2). Because the 95% limits of agreement for
static lung volumes include zero, it is not possible to conclude
that the helium dilution method systematically underestimates
static lung volumes in healthy individuals.
The reference equations for lung volumes from the healthy
older European women and men are given in Tables 2 and 3.
We did not find that the addition of transformations significantly improved the predictability of the regression equations.
No significant interaction between age and height was found.
Analysis of residuals showed that homoscedasticity was present
in all equations. Regression analysis of these residuals showed
neither statistically significant slopes nor correlation coeffi-
1086
2009
TABLE 2. LUNG VOLUME PREDICTION EQUATIONS FOR HEALTHY ELDERLY EUROPEAN WOMEN*
Equation
ERV, L
VC, L
IRV, L
IC, L
TLCpleth, L
FRCpleth, L
RVpleth, L
RV/TLCpleth, %
FRC/TLCpleth, %
IC/TLC, %
Raw, kPa/L/s
sRaw, kPa/s
TLC He, L
FRC He, L
RV He, L
RV/TLC He, %
FRC/TLC He, %
R2
RSD
0.150
0.552
0.162
0.219
0.437
0.304
0.061
0.085
0.047
0.047
0.155
0.069
0.412
0.243
0.120
0.086
0.092
0.3731
0.3214
0.4068
0.4199
0.5238
0.3902
0.4168
7.3748
8.3715
8.3649
0.2659
0.6912
0.5232
0.3999
0.3753
7.5377
7.9339
Definition of abbreviations: A 5 age in years; BMI 5 body mass index in kg/m2; BSA 5 body surface area in m2; H 5 height in
cm; RSD 5 residual standard deviation; W 5 weight in kg.
* The lower limit of normal is computed as: predicted value 1.645 3 RSD. The upper limit of normal is computed as:
predicted value 1 1.645 3 RSD.
TLC were with Crapo and colleagues (4) and ECSC (5),
whereas the closest for FRC was with Cordero and coworkers
(9) and ECSC (5) and for RV with Cordero and colleagues (9)
and Matthys and coworkers (7). In men, the closest TLC
agreements were with Crapo and colleagues (4) and Cordero
and coworkers (9), for FRC with Crapo and coworkers (4) and
Cotes and colleagues (10), and for RV with Matthys and
colleagues (2) and Crapo and coworkers (4).
To compare our reference equations with other prediction
equations, the difference in predicted lung volumes (present
study equation every other equation) by the mean predicted
lung volumes were plotted for women and men, respectively. In
women, Matthys and colleagues (7) and Roca and coworkers
(8) overestimated FRCpleth and FRCHe, whereas Cotes and
coworkers (10) underestimated this lung volume (Figure 3). In
men, the ratio increased proportionally when the present prediction values for FRCpleth were compared with those from
TABLE 3. LUNG VOLUME PREDICTION EQUATIONS FOR HEALTHY ELDERLY EUROPEAN MEN*
Equation
ERV, L
VC, L
IRV, L
IC, L
TLCpleth, L
FRCpleth, L
RVpleth, L
RV/TLCpleth, %
FRC/TLCpleth, %
IC/TLC, %
Raw, kPa/L/s
sRaw, kPa/s
TLC He, L
FRC He, L
RV He, L
RV/TLC He, %
FRC/TLC He, %
A3
W3
1 0.03028 H 0.000000959
23.907 1 0.000001217
2.064 0.00000320 A3 1 0.0000006171 H3
2.037 0.00000257 A3 1 0.0000009746 W3
2.327 0.00000455 A3 1 0.0000004124 H3
2.321 0.00000309 A3 1 0.0000009765 H3
21.425 1 0.02188 A 1 0.0000007418 H3 0.00000103 W3
0.315 1 0.0000003551 H3
11.590 1 0.314 A
32.759 1 0.00006201 A3
67.229 0.0000620 A3
1.717 1 0.005391 A 0.0117 H 1 0.000000414 W3
21.750 1 0.02208 A 1 0.05122 BMI
2.530 1 20.00000352 A3 1 0.0000009212 H3
0.838 1 0.0000004526 H3
22.703 1 0.03978 A 1 0.02261 W
23.79 1 0.00002066 A3
34.716 1 0.00005152 A3
R2
RSD
0.139
0.476
0.179
0.435
0.354
0.282
0.095
0.059
0.403
0.402
0.136
0.091
0.335
0.132
0.187
0.054
0.278
0.4299
0.4738
0.6054
0.5545
0.8001
0.4865
0.5369
6.8354
6.7594
6.7669
0.1564
0.4901
0.8429
0.5626
0.6184
8.1326
7.7813
Definition of abbreviations: A 5 age in years; BMI 5 body mass index in kg/m2; BSA 5 body surface area in m2; H 5 height in
cm; RSD 5 residual standard deviation; W 5 weight in kg.
* The lower limit of normal is computed as: predicted value 1.645 3 RSD. The upper limit of normal is computed as:
predicted value 1 1.645 3 RSD.
1087
Women
ERV, L
VC, L
IRV, L
TLCpleth, L
FRCpleth, L
Raw, kPa/L/s
sRaw, kPa/s
TLC He, L
FRC He, L
FRC/TLC He, %
Men
ERV, L
IRV, L
FRCpleth, L
Raw, kPa/L/s
sRaw, kPa/s
RV He, L
Equation
R2
RSD
0.07476 0.0000002534 H3
2.90 0.03375 A 1 0.0000005504 H3
1.932 0.02309 A 1 0.0000001885 H3
12.383 0.243 A 1 0.00001271 A3 1 0.0001824 H2
0.563 1 0.0000004998 H3
0.546 1 0.009432 A 0.00003178 H2
20.542 1 0.02527 A
21.690 0.03779 A 1 0.05354 H
22.427 1 0.02976 H
29.951 1 0.372 A
0.080
0.524
0.149
0.416
0.233
0.100
0.041
0.379
0.159
0.060
0.3859
0.3301
0.4099
0.5223
0.4083
0.2735
0.6996
0.5358
0.4199
8.0392
0.098
0.143
0.251
0.056
0.043
0.037
0.4384
0.6162
0.4949
0.1621
0.5008
0.5313
22.131
2.543
21.215
1.443
20.204
0.771
1 0.000001359 A3 1 0.01691 H
0.00000285 A3
1 0.02434 A 1 0.0000005659 H3
0.006653 H
1 0.01949 A
1 0.0000002113 H3
Definition of abbreviations: A 5 age in years; BMI 5 body mass index in kg/m2; BSA 5 body surface area in m2; H 5 height in
cm; RSD 5 residual standard deviation; W 5 weight in kg.
* The lower limit of normal is computed as: predicted value 1.645 3 RSD. The upper limit of normal is computed as:
predicted value 1 1.645 3 RSD.
DISCUSSION
To our knowledge, the current study provides the first data in
the international literature on reference values for static lung
volumes and airway resistance in healthy older adults. Our
results confirm that reference equations should not be extrapolated, in general, for ages or heights beyond those covered by
the data that generated them. For patients over 65 years of age,
the current study shows that the most commonly used sets of
reference equations may lead to inaccurate interpretations.
The exact definition of a healthy group is difficult to agree
upon. Although criteria to define subjects as healthy have been
established in previous ATS statements (22), previous studies
have used many different criteria. The ECSC reference equations (5, 6) were not based on original data; rather, they were
derived from previously published reference equations. Moreover, the data on TLC, RV, and FRC are derived from
TABLE 5. COMPARISON BETWEEN OBSERVED PLETHYSMOGRAPHIC LUNG VOLUMES AND THE PREDICTED VALUES DERIVED FROM
DIFFERENT REFERENCE EQUATIONS
Women
TLC
Present
ECSC (5)
Crapo (4)
Cordero (9)
Roca (8)
Matthys (7)
FRC
Present
ECSC (5)
Crapo (4)
Cordero (9)
Roca (8)
Matthys (7)
Cotes (10)
RV
Present
ECSC (5)
Crapo (4)
Cordero (9)
Roca (8)
Matthys (7)
Men
Mean
Difference (%)
Mean
Squared
Difference
Standardized
Prediction
Deviation
% Observed
Values below the
LLN or over ULN*
Rank
Mean
Difference (%)
Mean
Squared
Difference
Standardized
Prediction
Deviation
% Observed
Values Below the
LLN or over ULN*
Rank
24.0
217.8
223.6
214.8
236.8
228.9
0.552
0.745
0.851
0.699
1.098
0.956
20.094
21.308
21.826
21.043
22.826
22.156
5.7
23.4
40.8
17.9
62.5
50.0
1
3
4
2
6
5
22.2
213.3
211.6
213.3
225.7
218.4
0.731
0.832
0.808
0.842
1.063
0.922
0.001
20.689
20.571
20.698
21.464
21.024
4.3
16.4
12.5
15.6
42.2
25.0
1
3
2
4
6
5
23.3
216.0
216.8
24.8
222.0
217.9
21.5
0.402
0.599
0.612
0.476
0.666
0.624
0.665
20.035
20.809
20.843
0.146
21.137
20.866
1.363
1.3
1.6
1.1
5.4
0
0
22.8
1
3
4
2
7
5
6
22.5
212.9
24.2
212.9
216.4
214.3
211.8
0.583
0.651
0.595
0.641
0.685
0.666
0.634
20.005
20.593
20.100
20.660
20.848
20.716
20.592
3.9
0.8
2.3
0.8
0.8
0.8
0.8
1
5
2
4
7
6
3
23.5
238.2
247.7
221.7
246.2
231.1
0.497
0.710
0.778
0.597
0.765
0.660
20.003
21.447
21.749
20.894
21.728
21.173
2.2
0
0
0
0
0
1
4
6
2
5
3
211.4
246.8
229.9
234.8
247.9
229.1
0.571
0.750
0.628
0.645
0.755
0.627
0.002
21.072
20.564
20.724
21.134
20.536
2.3
0
0
0
0
0
1
5
3
4
6
2
* Lower limit of normal (LLN) range was calculated as predicted value RSD 3 1.645. Upper limit of normal (ULN) range was calculated as predicted value 1 RSD 3
1.645. Rank of the mean square difference is shown. Upper limit of normal is applicable to FRC and RV.
1088
2009
TABLE 6. COMPARISON BETWEEN OBSERVED DILUTIONAL LUNG VOLUMES AND THE PREDICTED VALUES DERIVED FROM
DIFFERENT REFERENCE EQUATIONS*
Women
TLC
Present
ECSC (5)
Crapo (4)
Cordero (9)
Roca (8)
Matthys (7)
FRC
Present
ECSC (5)
Crapo (4)
Cordero (9)
Roca (8)
Matthys (7)
Cotes (10)
RV
Present
ECSC (5)
Crapo (4)
Cordero (9)
Roca (8)
Matthys (7)
Men
Rank
Mean
Difference %
Mean
Squared
Difference
Standardized
Prediction
Deviation
% Observed
Values below the
LLN or over ULN
Rank
4.3
31.9
48.6
23.9
75.4
60.1
1
3
4
2
6
5
1.6
213.3
211.6
213.3
225.7
218.4
0.756
0.832
0.808
0.842
1.063
0.922
0.260
20.689
20.571
20.698
21.464
21.024
3.1
16.4
12.5
15.6
42.2
25.0
1
3
2
4
6
5
20.084
21.035
21.125
20.462
21.401
21.183
0.975
4.3
1.4
0.0
2.2
0.0
0.0
26.1
1
4
5
2
7
6
3
24.8
212.9
25.2
212.9
216.4
214.3
211.8
0.422
0.651
0.595
0.641
0.685
0.666
0.634
0.151
20.593
20.200
20.660
20.848
20.716
20.592
3.3
1.6
2.3
0.8
0.8
0.8
0.8
1
5
2
4
7
6
3
20.079
21.636
21.943
21.099
21.891
21.417
3.6
0
0
1.4
0
0
1
4
6
2
5
3
8.3
246.8
229.9
234.8
247.9
229.1
0.581
0.750
0.628
0.645
0.755
0.627
0.509
21.072
20.564
20.724
21.134
20.536
5.0
0
0
0
0
0
1
5
3
4
6
2
Mean
Difference %
Mean
Squared
Difference
Standardized
Prediction
Deviation
% Observed
Values below the
LLN or over ULN
23.1
219.8
225.2
217.3
238.4
230.9
0.546
0.790
0.893
0.744
1.107
0.993
20.117
21.202
21.582
21.053
22.461
21.938
24.8
224.4
226.4
212.2
232.0
228.7
16.2
0.521
0.645
0.671
0.552
0.739
0.705
0.605
210.1
254.5
263.9
239.1
261.7
248.6
0.484
0.741
0.813
0.624
0.794
0.700
* Lower limit of normal range (LLN) was calculated as predicted value RSD 3 1.645. Upper limit of normal range (ULN) was calculated as predicted value 1 RSD 3
1.645. Rank of the mean square difference is shown.
1089
Figure 3. Difference between plethysmographic FRC and mean FRC predicted by the present study versus (A) ECSC and colleagues (5), (B) Crapo
and colleagues (4), (C) Cordero and colleagues (9), (D) Roca and colleagues (8), (E) Matthys and colleagues (7), and (F) Cotes and colleagues (10) in
women.
1090
2009
Figure 4. Difference between plethysmographic FRC and mean FRC predicted by the present study versus (A) ECSC and colleagues (5), (B) Crapo
and colleagues (4), (C) Cordero and colleagues (9), (D) ROCA and colleagues (8), (E) Matthys and colleagues (7), and (F) Cotes and colleagues (10)
in men.
References
1. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R,
Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, et al.
Interpretative strategies for lung function tests. Eur Respir J 2005;26:
948968.
2. Pellegrino R, Brusasco V. Lung hyperinflation and flow limitation in
chronic airway obstruction. Eur Respir J 1997;10:543549.
3. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, PintoPlata V, Celli BR. Inspiratory-total lung capacity ratio predicts
mortality in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 2005;171:591597.
4. Crapo RO, Morris AH, Clayton PD, Nixon CR. Lung volumes in
healthy non-smoking adults. Bull Eur Physiopathol Respir 1982;18:
419425.
5. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault
JC. Lung volumes and forced ventilatory flows. Report Working
Party Standardization of Lung Function Tests, European Community
for Steel and Coal. Official Statement of the European Respiratory
Society. Eur Respir J 1993;6:540.
6. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. Eur Respir J 1995;8:
492506.
7. Matthys H, Zaiss AW, Theissen JL, Virchow JCJR, Werner P. Definition, normal reference and measured values to diagnose obstructive,
restrictive and mixed ventilatory defects for clinical lung function
evaluation. Atemwege-Lungenkrankheiten 1995;3:130138.
8. Roca J, Burgos F, Barbera JA, Sunyer J, Rodriguez-Roisin R, Castellsague
J, Sanchos J, Anto JM, Casan P, Clausen JL. Prediction equations
for plethysmographic lung volumes. Respir Med 1998;92:454460.
9. Cordero PJ, Morales P, Benlloch E, Miravet L, Cebrian J. Static lung
volumes: reference values from a Latin population of Spanish descent. Respiration 1999;66:242250.
10. Cotes JE, Chinn DJ, Reed JW. Body mass, fat percentage, and fat free
mass as reference variables for lung function: effects on terms for age
and sex. Thorax 2001;56:839844.
11. Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H,
Rosenthal M, Corey M, Lebcque P, Cole TJ. Reference ranges for
spirometry across all ages: a new approach. Am J Respir Crit Care
Med 2008;177:253260.
12. Chan ED, Welsh CH. Geriatric respiratory medicine. Chest 1998;114:
17041733.
13. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory
function associated with ageing. Eur Respir J 1999;13:197205.
1091
14. Murray JF. Aging: the normal lung. 2nd ed. Philadelphia, PA: W.R.
Saunders; 1986.
15. Mays PK, Rishop JE, Laurent GJ. Age-related changes in the proportion of types I and III collagen. Mech Ageing Dev 1988;45:
203212.
16. Rraman SS. Aging and the lung: physiology and clinical consequences.
Pulm Perspectives, Northbrook, IL. Am. College Chest Physicians
1997;14:68.
17. Garcia-Rio F, Pino JM, Dorgham A, Alonso A, Villamor J. Spirometric
reference equations for European females and males aged 6585 yrs.
Eur Respir J 2004;24:397405.
18. Minette A. Questionnaire of the European Community for Coal and
Steel (ECSC) on respiratory symptoms. Eur Respir J 1989;2:165177.
19. Miller MR, Hankinson J, Brusasco V, Bugos F, Casaburi R, Coates A,
Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. ATS/
ERS Task Force. Standardization of spirometry. Eur Respir J 2005;26:
319338.
20. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F,
Casaburi R, Crapo R, Enright P, van der Grinten CP, et al. Viegi
standardization of the measurement of lung volumes. Eur Respir J
2005;26:511522.
21. Bland JM, Altman DG. Statistical methods for assessing agreement
between two methods of clinical measurements. Lancet 1986;i:307310.
22. American Thoracic Society. Lung function testing: selection of reference
values and interpretative strategies. Am Rev Respir Dis 1991;144:
12021218.
23. Sue DY. Obesity and pulmonary function, more or less? Chest 1997;111:
844845.
24. Polkey MI, Harris ML, Hughes PD, Hamnegard CH, Lyons D, Green
M, Moxham J. The contractile properties of the elderly human
diaphragm. Am J Respir Crit Care Med 1997;155:15601564.
25. Enright PL, Kronmal RA, Manolio TA, Schenker MB, Hyatt RE.
Respiratory muscle strength in the elderly: correlates and reference
values. Am J Respir Crit Care Med 1994;149:430438.
26. Mizuno M. Human respiratory muscles: fiber morphology and capillary
supply. Eur Respir J 1991;4:587601.
27. Lang M, Fiaux G, Gillooly M, Stewart J, Hulmes D, Lamb D. Collagen
content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax 1994;49:319326.
28. Teramoto S, Fukuchi Y, Uejima Y, Teramoto K, Oka T, Orimo H. A
novel model of senile lung: senescence accelerated mouse (SAM).
Am J Respir Crit Care Med 1994;150:238244.
29. Kurozumi M, Matsushita T, Hosokawa M, Takeda T. Age-related
changes in lung structure and function in the senescence-accelerated
mouse (SAM): SAM-P/1 as a new murine model of senile hyperinflation of lung. Am J Respir Crit Care Med 1994;149:776782.